Only 1 of 10 CEOs ‘positive’ about drug regulations in KOR
By Chon, Seung-Hyun | translator Alice Kang
24.01.02 06:20:32
가나다라
0
New Year’s Pharmaceutical & Bio CEO Survey ① Perception of Government Regulations in Korea
Only 2 out of 53 CEOs 'positive' about government’s regulations... dissatisfaction over drug pricing and reimbursement at an ‘all high’
Satisfaction scores regarding regulations for approval, drug pricing, and sales are all less than 5 out of 10... Satisfaction score for drug pricing regulations is the ‘lowest’ at 3.15 points
▲2024 Pharma-Bio CEO Survey: Business strategies and perceptions on regulations in Korea
A survey showed only 1 in 10 CEOs of pharmaceutical companies were found to be satisfied with the Korean health authorities' regulatory policies for the pharmaceutical industry. In all major regulatory areas such as approvals, drug pricing, and sales, the satisfaction rate of CEOs was more negative than positive towards the set regulations. In particular, the CEOs expressed the least satisfaction with Korea’s drug pricing and reimbursement regulations.
According to a survey Dailypharm conducted on 53 CEOs of pharmaceutical companies on their perception of government regulations in Korea, only 8% of the respondents expressed positivity towards the government regulations made for the pharmaceuti
Chon, Seung-Hyun(1000@dailypharm.com)
If you want to see the full article, please JOIN US (click)